日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

登録内容を編集ファイル形式で保存
 
 
ダウンロード電子メール
  Design and Synthesis of Antisense Peptide Nucleic Acid Conjugated MR Contrast Agents [Design und Synthese von Antisense Peptid-Nukleinsäure konjugierten MR Kontrastmitteln]

Su, W. (2007). Design and Synthesis of Antisense Peptide Nucleic Acid Conjugated MR Contrast Agents [Design und Synthese von Antisense Peptid-Nukleinsäure konjugierten MR Kontrastmitteln]. PhD Thesis, Eberhard-Karls-Universität, Tübingen, Germany.

Item is

基本情報

表示: 非表示:
アイテムのパーマリンク: https://hdl.handle.net/21.11116/0000-0004-4386-9 版のパーマリンク: https://hdl.handle.net/21.11116/0000-0004-4387-8
資料種別: 学位論文

ファイル

表示: ファイル

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Su, W1, 2, 著者           
所属:
1Former Department MRZ, Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_2528700              
2Max Planck Institute for Biological Cybernetics, Max Planck Society, Spemannstrasse 38, 72076 Tübingen, DE, ou_1497794              

内容説明

表示:
非表示:
キーワード: -
 要旨: Magnetic Resonance Imaging (MRI) is one of the most important diagnostic tools available in medicine. The specificity and sensitivity of MRI can be further enhanced by the introduction of contrast agents. As many clinically valuable targets reside inside the cell membrane, therefore, developing efficient intracellular targeted MR contrast agent is required. The objective of the present project is to construct novel targeted intracellular MR contrast agents aiming to image mRNA transcription by MRI. The first part of this thesis takes an effort to search for an optimal vector for the intracellular delivery of MR contrast agents. Eight intracellular MR contrast agents, which conjugate different cell-penetrating peptides (CPP) with FITC and Gd(III) complexes, were synthesized by a continuous solid phase synthesis scheme. The key intermediates and final products were characterized by ESI-MS. Relaxivities of these MR contrast agents were measured at a frequency of 123 MHz and a magnetic field of 3 T. The comparison studies of the uptake and toxicity on NIH/3T3 cells suggest that D-Tat57-49 contrast agent could label cells sufficient to enhance significantly relaxation rates R1 and R2 for MR measurements, thus D-Tat57-49 peptide proves to be a useful CPP for the development of new intracellular MR contrast agents. The second part of this thesis describes the design and synthesis of antisense MR contrast agents, which conjugate PNA with CPP, Gd-DOTA and FITC. The intracellular uptake was confirmed by fluorescence spectroscopy, fluorescence microscopy and MR imaging on NIH/3T3 mouse fibroblasts as well as on transgenic dsRed cells. A subtoxic labeling concentration of 0.5 µM is sufficient to enhance significantly MR imaging contrast. The intracellular Gd(III) contents are at the range of 10-9~10-8 mol Gd/107 cells. An in vitro PNA-DNA binding assay confirmed that there is a significant higher specificity of the dsRed antisense contrast agent in comparison to its non-sense counterpart. However, no specific accumulation of the antisense dsRed CA in comparison to the non-sense CA could be detected in the target containing dsRed cells. Fluorescence microscopy studies have showed an exclusive endosomal localization of the contrast agents. Thus, further modifications of the contrast agents are required to achieve the release from endosomes or a direct uptake into the cytosol.

資料詳細

表示:
非表示:
言語:
 日付: 2007-10-262007
 出版の状態: 出版
 ページ: 107
 出版情報: Tübingen, Germany : Eberhard-Karls-Universität
 目次: -
 査読: -
 識別子(DOI, ISBNなど): -
 学位: 博士号 (PhD)

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物

表示: